Pharma Journalist - Page 689 of 834 -

Axcynsis Receives FDA Clearance for IND of AT03-65, CLDN6-Targeting ADC

FDA Approves Lilly’s Omvoh for Crohn’s Disease, Expanding IBD Treatment Options

AbbVie and Simcere Zaiming Partner to Develop Trispecific Antibody for Multiple Myeloma

Alfa Scientific Designs assert FDA 510(k) clearance for Driven Flow Technology

Hear from MedImmune and Ipsen at SMi’s Injectable Drug Delivery 2018

MabSpace Biosciences declares FDA approval of IND for MSB2311

FDA clearance received for Endomag’s Magseed Marker

Kadmon declares updated optimistic results of Phase 2 study of KD025-208 in cGVHD

Puma Biotechnology asserts CHMP’s negative opinion on MAA for Neratinib

Pfizer declares update on EMAP for SUTENT in RCC patients

CEL-SCI extends the Expiration Date of Series DD and Series EE Warrants issued

PacBridge Capital Partners (HK) acquires Contextual Genomics

Pfizer sought CHMP Opinion for MYLOTARG and BOSULIF